M3V — MeVis Medical Solutions AG Balance Sheet
0.000.00%
Last trade - 00:00- €44.04m
- €37.52m
- €16.06m
- 93
- 49
- 61
- 81
Annual balance sheet for MeVis Medical Solutions AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 7.62 | 9.32 | 7.74 | 6.53 | 6.52 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.8 | 4.74 | 3.27 | 2.77 | 2.18 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10.9 | 14.5 | 11.4 | 9.64 | 9.05 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.122 | 0.162 | 0.146 | 0.315 | 0.309 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 27.5 | 31.2 | 28.1 | 26.5 | 25.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.69 | 9.67 | 6.85 | 6.36 | 5.72 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.71 | 13.4 | 10.2 | 8.66 | 8.06 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 17.8 | 17.8 | 17.8 | 17.8 | 17.8 |
| Total Liabilities & Shareholders' Equity | 27.5 | 31.2 | 28.1 | 26.5 | 25.9 |
| Total Common Shares Outstanding |